Table 5: Treatment and outcomes.

Treatment of NPSLE

n(%)

Intravenous methyl prednisolone

Cyclophosphamide

Mycophenolate mofetil

Rituximab

Intravenous Immunoglobulin

Plasmapheresis

Antiplatelet

Anticoagulant

Anticonvulsant

Psychiatric treatment

13(72.2)

10(66.7)

5(27.8)

4(22.2)

2(11.1)

1(5.6)

3(16.7)

2(11.1)

5(27.8)

3(16.7)

Outcomes

n(%)

Clinical improvement

Relapsing NPSLE

Death

Diffuse alveolar hemorrhage

Ischaemic heart disease

Unknown

12(66.7)

3(16.7)

3(16.7)

1(5.6)

1(5.6)

1(5.6)